Axsome Therapeutics, Inc. · NASDAQ:AXSM
Jacobson Mark L. sold 10,000 Axsome Therapeutics, Inc. shares (Form 4)
Traded Sep 3, 2026 · Filed Sep 3, 2026
On Sep 3, 2026, Jacobson Mark L. (Chief Operating Officer) sold 10,000 Axsome Therapeutics, Inc. shares at US$208.65 for US$2.09M under a trading plan, leaving 0 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$208.65
- Value
- US$2.09M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | Option exercise | 10,000 | US$12.95 | 10,000 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 10,000 | US$208.65 | 0 | Direct |
Source
Related
- Axsome Therapeutics, Inc.
- Jacobson Mark L.
- Axsome Therapeutics, Inc. shareholders
- Form 4 · Jacobson Mark L. · May 5, 2026
- Form 4 · Tabuteau Herriot · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Tabuteau Herriot · Jul 1, 2026
- Form 4 · Jeffs Roger · Jun 11, 2026
- Form 4 · Mahony Susan · Jun 10, 2026